373 related articles for article (PubMed ID: 6261179)
1. The site of inhibitory action of a natural (corticosterone) and synthetic steroid (dexamethasone) in the hypothalamic-pituitary-adrenal axis.
Sakakura M; Yoshioka M; Kobayashi M; Takebe K
Neuroendocrinology; 1981 Mar; 32(3):174-8. PubMed ID: 6261179
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic maternal dexamethasone treatment on the hormones of the hypothalamo-pituitary-adrenal axis in the rat fetus.
Dupouy JP; Chatelain A; Boudouresque F; Conte-Devolx B; Oliver C
Biol Neonate; 1987; 52(4):216-22. PubMed ID: 2823915
[TBL] [Abstract][Full Text] [Related]
3. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
[TBL] [Abstract][Full Text] [Related]
4. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
Huang TS
J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
[TBL] [Abstract][Full Text] [Related]
5. ACTH content in the anterior pituitary after the infusion of various doses of corticosterone and dexamethasone in normal and adrenalectomized rats.
Sakakura M; Yoshioka M; Kobayashi M
Tohoku J Exp Med; 1982 Jun; 137(2):191-8. PubMed ID: 6287667
[TBL] [Abstract][Full Text] [Related]
6. Degree of inhibition of ACTH release by glucocorticoids in adrenalectomized rats.
Sakakura M; Yoshioka M; Kobayashi M; Takebe K
Neuroendocrinology; 1981 Jan; 32(1):38-41. PubMed ID: 6258095
[TBL] [Abstract][Full Text] [Related]
7. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
8. Recovery of the hypothalamo-pituitary-adrenocortical axis in the rat after long-term dexamethasone treatment.
Nicholson S; Campbell E; Torrellas A; Beckford U; Altaher R; Sandford R; Scraggs R; Gillham B; Jones M
Neuroendocrinology; 1984 Oct; 39(4):343-9. PubMed ID: 6092989
[TBL] [Abstract][Full Text] [Related]
9. Effects of treatment with adrenocorticotrophin on the hypothalamo-pituitary-adrenal system.
Stark E; Kárteszi M; Rappay G; Makara GB
J Endocrinol; 1981 Jan; 88(1):131-9. PubMed ID: 6257818
[TBL] [Abstract][Full Text] [Related]
10. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
11. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis.
Oitzl MS; van Haarst AD; Sutanto W; de Kloet ER
Psychoneuroendocrinology; 1995; 20(6):655-75. PubMed ID: 8584606
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
[TBL] [Abstract][Full Text] [Related]
13. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
[TBL] [Abstract][Full Text] [Related]
14. Seasonal changes in hypothalamic-pituitary-adrenal axis sensitivity in free-living house sparrows (Passer domesticus).
Romero LM
Gen Comp Endocrinol; 2006 Oct; 149(1):66-71. PubMed ID: 16828761
[TBL] [Abstract][Full Text] [Related]
15. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
[TBL] [Abstract][Full Text] [Related]
17. Free fatty acids activate the hypothalamic-pituitary-adrenocortical axis in rats.
Widmaier EP; Rosen K; Abbott B
Endocrinology; 1992 Nov; 131(5):2313-8. PubMed ID: 1330498
[TBL] [Abstract][Full Text] [Related]
18. Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age.
Cizza G; Calogero AE; Brady LS; Bagdy G; Bergamini E; Blackman MR; Chrousos GP; Gold PW
Endocrinology; 1994 Apr; 134(4):1611-20. PubMed ID: 8137722
[TBL] [Abstract][Full Text] [Related]
19. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test.
Miller AH; Spencer RL; Pulera M; Kang S; McEwen BS; Stein M
Biol Psychiatry; 1992 Nov; 32(10):850-69. PubMed ID: 1334712
[TBL] [Abstract][Full Text] [Related]
20. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
